¼¼°èÀÇ ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå
Cell Culture Media
»óǰÄÚµå : 1774698
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 673 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀåÀº 2030³â±îÁö 77¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 42¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼Æ÷¹è¾ç ¹èÁö ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 10.7%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 77¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¾×ü ¹Ìµð¾î´Â CAGR 11.7%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 56¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹Ý°íü ¹× °íü ¹Ìµð¾î ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 8.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 15¾ï ´Þ·¯·Î ÃßÁ¤¡¤Áß±¹Àº CAGR15.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀåÀº 2024³â¿¡´Â 15¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6¾ï 9,190¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 15.5%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 8.2%¿Í 10.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 9.8%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¼¼Æ÷¹è¾ç ¹èÁö ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¼¼Æ÷¹è¾ç ¹èÁö¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

¼¼Æ÷¹è¾ç ¹èÁö ¼ö¿ä´Â ¹ÙÀÌ¿À ÀǾàǰ ¿¬±¸, Àç»ýÀÇ·á, ¼¼Æ÷ ±â¹Ý Ä¡·áÀÇ ±Þ¼ÓÇÑ È®´ë·Î ÀÎÇØ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼¼Æ÷¹è¾ç ¹èÁö´Â ÀǾàǰ °³¹ß, ¹é½Å Á¦Á¶, Áٱ⼼Æ÷ ¿¬±¸¿¡ »ç¿ëµÇ´Â ¼¼Æ÷ÀÇ ¼ºÀå, À¯Áö, Áõ½ÄÀ» Áö¿øÇÏ´Â Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ´ÜŬ·Ð Ç×ü, À¯ÀüÀÚ Ä¡·áÁ¦, ¸é¿ª Ä¡·áÁ¦¸¦ Æ÷ÇÔÇÑ »ý¹°ÇÐÀû Á¦Á¦¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó °íǰÁúÀÇ Æ¯¼ö ¹è¾ç¾×¿¡ ´ëÇÑ Çʿ伺ÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Á¤¹ÐÀÇ·á¿Í Á¶Á÷°øÇÐÀÇ ¹ßÀüÀº ¸ÂÃãÇü È­ÇÐÀûÀ¸·Î Á¤ÀÇµÈ ¹èÁö Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸±â°ü°ú Á¦¾àȸ»çµéÀº »ý»ê¼º, ÀçÇö¼º, ¼¼Æ÷ »ýÁ¸À²À» ³ôÀ̱â À§ÇØ ¼¼Æ÷ ¹è¾ç Á¶°ÇÀ» Áö¼ÓÀûÀ¸·Î ÃÖÀûÈ­Çϰí ÀÖ½À´Ï´Ù. ¼¼°è »ý¸í°øÇÐ ºÐ¾ß°¡ È®´ëµÊ¿¡ µû¶ó ¼¼Æ÷ ¹è¾ç ¹èÁö ½ÃÀåÀº °úÇÐÀû Çõ½Å°ú ¼¼Æ÷ ±â¹Ý ±â¼ú äÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô ¼¼Æ÷ ¹è¾ç ¹èÁö¸¦ °³¼±Çϰí Àִ°¡?

¹èÁö ¹èÇÕ, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼ú ¹× ÀÚµ¿È­ ºÐ¾ßÀÇ Çõ½ÅÀº ¼¼Æ÷ ¹è¾ç ¹èÁöÀÇ È¿À²¼º°ú È®À强À» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ ¹ßÀü Áß Çϳª´Â ¹«Ç÷û ¹èÁö ¹× È­ÇÐÀûÀ¸·Î Á¤ÀÇµÈ ¹èÁöÀÇ °³¹ß·Î, ¼¼Æ÷ ±â¹Ý ½ÇÇè ¹× Á¦Á¶ÀÇ º¯µ¿À» ¾ø¾Ö°í Àϰü¼ºÀ» Çâ»ó½ÃŰ´Â °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¹èÁö´Â ±ÔÁ¦ Áؼö¿Í ÀçÇö¼ºÀÌ Áß¿äÇÑ ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶¿¡¼­ ƯÈ÷ °¡Ä¡°¡ ÀÖ½À´Ï´Ù.

¹è¾ç Á¶°Ç ÃÖÀûÈ­¿¡ ÀÖ¾î ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº ¶Ç ´Ù¸¥ ȹ±âÀûÀÎ ¹ßÀüÀ¸·Î, ÀΰøÁö´É ±â¹Ý ¸ðµ¨Àº ¹æ´ëÇÑ µ¥ÀÌÅÍ ¼¼Æ®¸¦ ºÐ¼®ÇÏ¿© ¹èÁö ±¸¼ºÀ» ¹Ì¼¼ Á¶Á¤ÇÏ¿© ¼¼Æ÷ ¼öÀ²°ú »ý»ê¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, 3D ¼¼Æ÷ ¹è¾ç°ú ¿À°¡³ëÀÌµå ±â¼úÀÇ ¹ßÀüÀ¸·Î º¹ÀâÇÑ ¼¼Æ÷ ±¸Á¶¿¡ ¸Â´Â ¹èÁö¸¦ °³¹ßÇÒ ¼ö ÀÖ´Â »õ·Î¿î ±âȸ°¡ »ý°Ü³ª°í ÀÖ½À´Ï´Ù. ¹èÁö ±¸¼ºÀ» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ¹ÙÀÌ¿À¸®¾×ÅÍ ½Ã½ºÅÛÀÇ »ç¿ëÀº »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹é½ÅÀÇ ´ë±Ô¸ð »ý»êÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÚµ¿È­ ¹× µ¥ÀÌÅÍ ±â¹Ý Á¢±Ù ¹æ½ÄÀÌ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó ¼¼Æ÷ ¹è¾ç ¹èÁö´Â ´õ¿í Àü¹®È­µÇ°í, È¿À²ÀûÀ̸ç, ¿ëµµ¿¡ ¸Â°Ô ƯȭµÇ¾î °¡°í ÀÖ½À´Ï´Ù.

¼¼Æ÷¹è¾ç¹èÁö »ê¾÷ÀÇ ¼ºÀåÀ» ÁÖµµÇÏ´Â ½ÃÀå µ¿ÇâÀº?

»ý¹°ÇÐÀû Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ¼¼Æ÷¹è¾ç¹èÁö ½ÃÀåÀ» Çü¼ºÇÏ´Â °¡Àå ¿µÇâ·Â ÀÖ´Â Æ®·»µå Áß ÇϳªÀÔ´Ï´Ù. ¹ÙÀÌ¿À Á¦¾à ±â¾÷µéÀº ´ÜŬ·Ð Ç×ü, ÀçÁ¶ÇÕ ´Ü¹éÁú, ¼¼Æ÷ ±â¹Ý ¹é½Å °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ ¸ðµç °ÍµéÀº ´ë·® »ý»ê¿¡ ÃÖÀûÈ­µÈ ¹èÁö¸¦ ÇÊ¿ä·Î ÇÕ´Ï´Ù. ¶ÇÇÑ, ¼¼Æ÷Ä¡·á ¹× À¯ÀüÀÚÄ¡·á ¿¬±¸ÀÇ È®´ë·Î Áٱ⼼Æ÷ÀÇ Áõ½Ä ¹× ºÐÈ­¸¦ Áö¿øÇÏ´Â °í¼º´É ¹èÁö Á¦Á¦¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ Æ®·»µå´Â µ¿¹° ½ÇÇèÀ» ÇÏÁö ¾Ê´Â Áö¼Ó °¡´ÉÇÑ ¹èÁö ¼ººÐÀ¸·ÎÀÇ ÀüȯÀÔ´Ï´Ù. À±¸®Àû ¿ì·Á¿Í ±ÔÁ¦ ´ç±¹ÀÇ ¾Ð·ÂÀ¸·Î ÀÎÇØ ¼Ò ÅÂ¾Æ Ç÷û(FBS)¿¡¼­ ÀçÁ¶ÇÕ ¹èÁö ¹× ½Ä¹° À¯·¡ ¹èÁö º¸ÃæÁ¦·ÎÀÇ ÀüȯÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ ºÎ»óÀ¸·Î ƯÁ¤ ȯÀÚ À¯·¡ ¼¼Æ÷ÁÖ ¸ÂÃãÇü ¹èÁö¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³¹ß ¹× Á¦Á¶¼öʱâ°ü(CDMO)ÀÇ È®´ëµµ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¾Æ¿ô¼Ò½Ì ±â¾÷µéÀÌ ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶¸¦ À§ÇØ È®Àå °¡´ÉÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¹èÁö ¼Ö·ç¼ÇÀ» ÇÊ¿ä·Î Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¾÷°è°¡ º¸´Ù È¿À²ÀûÀ̰í À±¸®ÀûÀÎ ¼¼Æ÷ ¹è¾ç °üÇàÀ¸·Î ÀüȯÇÔ¿¡ µû¶ó ½ÃÀåÀÇ ±â¼ú Çõ½ÅÀº Á¡Á¡ ´õ Ȱ¹ßÇØÁö°í ÀÖ½À´Ï´Ù.

¼¼Æ÷ ¹è¾ç ¹èÁö ½ÃÀåÀÇ ¹Ì·¡¸¦ Çü¼ºÇÏ´Â ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

¼¼Æ÷¹è¾ç¹èÁö ½ÃÀåÀÇ ¼ºÀåÀº ¹ÙÀÌ¿ÀÀǾàǰ »ý»ê¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, Àç»ýÀÇ·áÀÇ ¹ßÀü, ¹é½Å ¹× Ä¡·á¿ë ´Ü¹éÁú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â Ç×ü ±â¹Ý Ä¡·áÁ¦¿Í À¯ÀüÀÚ º¯Çü ¼¼Æ÷ Ä¡·áÁ¦¸¦ Æ÷ÇÔÇÑ »ý¹°ÇÐÀû Á¦Á¦ ÆÄÀÌÇÁ¶óÀÎÀÇ È®´ëÀÔ´Ï´Ù. Á¦¾àȸ»çµéÀÌ È¿À²ÀûÀ̰í ÀçÇö¼ºÀÌ ³ôÀº ¼¼Æ÷ ¹è¾ç ½Ã½ºÅÛÀ» ¿ä±¸ÇÔ¿¡ µû¶ó Ư¼ö ¹èÁö¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀ» Çü¼ºÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ÃËÁø¿äÀÎÀº ¼¼Æ÷ ¹è¾ç ¿öÅ©Ç÷ο쿡¼­ ÀÚµ¿È­ ¹× ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÃÖÀûÈ­ÀÇ ¿ªÇÒÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÚµ¿ ¾×ü ó¸® ½Ã½ºÅÛ, ÇÏÀ̽º·çDz ½ºÅ©¸®´× Ç÷§Æû, AI¸¦ ÅëÇÑ ¹èÁö ÃÖÀûÈ­´Â ¹ÙÀÌ¿À Á¦Á¶ÀÇ ºñ¿ë Àý°¨°ú È®À强 Çâ»óÀ» °¡Á®¿À°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áٱ⼼Æ÷ ¿¬±¸¿Í Á¤¹ÐÀÇ·á ±¸»ó¿¡ ´ëÇÑ Á¤ºÎÀÇ ÀÚ±Ý Áö¿øÀ¸·Î ÷´Ü ¼¼Æ÷¹è¾ç ±â¼úÀÇ µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. °úÇÐÀû ¹ß°ßÀÌ ¼¼Æ÷ ¿¬±¸ÀÇ ÇѰ踦 °è¼Ó ³ÐÇô°¡°í ÀÖ´Â °¡¿îµ¥, Çõ½ÅÀûÀÌ°í °í¼º´ÉÀÇ ¹è¾ç ¹èÁö¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© »ý¸í°øÇÐ ¹× Ä¡·áÁ¦ °³¹ßÀÇ »õ·Î¿î ÁöÆòÀ» ¿­¾î°¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

À¯Çü(¾×ü ¹èÁö, ¹Ý°íü ¹èÁö, °íü ¹èÁö), ¹èÁö À¯Çü(¹«Ç÷û ¹èÁö, Áٱ⼼Æ÷ ¹èÁö, È­ÇÐÀû Á¤ÀÇ ¹èÁö, °íÀü ¹èÁö, Ư¼ö ¹èÁö, ±âŸ ¼¼Æ÷¹è¾ç ¹èÁö), ¿ëµµ(¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶ ¿ëµµ, Áø´Ü ¿ëµµ, Drug Discovery ½ºÅ©¸®´× ¹× °³¹ß ¿ëµµ, Á¶Á÷°øÇÐ ¹× Àç»ýÀÇ·á ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(Á¦¾à ±â¾÷ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ ÃÖÁ¾ ¿ëµµ,º´¿ø ¹× Áø´Ü½ÇÇè½Ç ÃÖÁ¾ ¿ëµµ, ¿¬±¸ ¹× Çмú±â°ü ÃÖÁ¾ ¿ëµµ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cell Culture Media Market to Reach US$7.7 Billion by 2030

The global market for Cell Culture Media estimated at US$4.2 Billion in the year 2024, is expected to reach US$7.7 Billion by 2030, growing at a CAGR of 10.7% over the analysis period 2024-2030. Liquid Media, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Semi-Solid & Solid Media segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 15.5% CAGR

The Cell Culture Media market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$691.9 Million by the year 2030 trailing a CAGR of 15.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.2% and 10.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global Cell Culture Media Market - Key Trends & Drivers Summarized

Why Is the Demand for Cell Culture Media Increasing?

The demand for cell culture media is rising due to the rapid expansion of biopharmaceutical research, regenerative medicine, and cell-based therapies. Cell culture media play a crucial role in supporting the growth, maintenance, and proliferation of cells used in drug development, vaccine production, and stem cell research. With increasing investments in biologics, including monoclonal antibodies, gene therapies, and immunotherapies, the need for high-quality and specialized culture media has significantly grown.

Additionally, advancements in precision medicine and tissue engineering have fueled the demand for customized and chemically defined media formulations. Research institutions and pharmaceutical companies are continuously optimizing cell culture conditions to enhance productivity, reproducibility, and cell viability. As the global biotechnology sector expands, the market for cell culture media is poised for continued growth, driven by scientific innovations and the increasing adoption of cell-based technologies.

How Are Technological Advancements Improving Cell Culture Media?

Innovations in media formulation, bioprocessing techniques, and automation are transforming the efficiency and scalability of cell culture media. One of the most significant advancements is the development of serum-free and chemically defined media, which eliminate variability and enhance consistency in cell-based experiments and manufacturing. These media are particularly valuable in biopharmaceutical production, where regulatory compliance and reproducibility are critical.

Another major breakthrough is the integration of artificial intelligence and machine learning in optimizing culture conditions. AI-driven models analyze vast datasets to fine-tune media compositions, improving cell yield and productivity. Additionally, advancements in 3D cell culture and organoid technology are creating new opportunities for media development tailored to complex cellular structures. The use of bioreactor systems with real-time monitoring of media composition is also enhancing large-scale production of biologics and vaccines. As automation and data-driven approaches continue to evolve, cell culture media are becoming more specialized, efficient, and application-specific.

Which Market Trends Are Driving Growth in the Cell Culture Media Industry?

The increasing adoption of biologics and biosimilars is one of the most influential trends shaping the cell culture media market. Biopharmaceutical companies are focusing on developing monoclonal antibodies, recombinant proteins, and cell-based vaccines, all of which require optimized media for large-scale production. The expansion of cell and gene therapy research has also led to increased demand for high-performance media formulations that support stem cell growth and differentiation.

Another key trend influencing market growth is the shift toward animal-free and sustainable media components. Ethical concerns and regulatory pressures have accelerated the move away from fetal bovine serum (FBS) toward recombinant and plant-derived media supplements. Additionally, the rise of personalized medicine is driving demand for media tailored to specific patient-derived cell lines. The expansion of contract development and manufacturing organizations (CDMOs) is also boosting the market, as outsourcing companies require scalable and cost-effective media solutions for biopharmaceutical production. As the industry moves toward more efficient and ethical cell culture practices, market innovation continues to thrive.

What Are the Key Growth Drivers Shaping the Future of the Cell Culture Media Market?

The growth in the cell culture media market is driven by several factors, including increasing investments in biopharmaceutical production, advancements in regenerative medicine, and the rising demand for vaccines and therapeutic proteins. One of the primary growth drivers is the expanding pipeline of biologics, including antibody-based therapies and gene-modified cell treatments. As pharmaceutical companies seek efficient and reproducible cell culture systems, demand for specialized media continues to rise.

Another crucial driver shaping the market is the increasing role of automation and bioprocess optimization in cell culture workflows. Automated liquid handling systems, high-throughput screening platforms, and AI-driven media optimization are reducing costs and improving scalability in biomanufacturing. Additionally, government funding for stem cell research and precision medicine initiatives is accelerating the adoption of advanced cell culture techniques. As scientific discoveries continue to push the boundaries of cellular research, the need for innovative, high-performance culture media is expected to grow, driving the market toward new frontiers in biotechnology and therapeutic development.

SCOPE OF STUDY:

The report analyzes the Cell Culture Media market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Liquid Media, Semi-Solid and Solid Media); Media Type (Serum-Free Media, Stem Cell Culture Media, Chemically Defined Media, Classical Media, Specialty Media, Other Cell Culture Media); Application (Biopharmaceutical Production Application, Diagnostics Application, Drug Screening and Development Application, Tissue Engineering and Regenerative Medicine Application, Other Applications); End-Use (Pharma and Biotech Companies End-Use, Hospitals and Diagnostic Laboratories End-Use, Research and Academic Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 53 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â